Gabapentin
- Product NDC
- 68151-1028
- 11-digit product format
- 681511028
- Labeler code
- 68151
- Product ID
- 68151-1028_ef5b0308-facf-4b40-ad45-fa9b7ac2829f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Carilion Materials Management
- Application
- ANDA075360
- Marketing category
- ANDA
- Marketing start
- 2005-04-06
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 100 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 68151-1028 | I | Inactivated by FDA | 2026-08-03 | ||
| excluded package | package | 68151-1028 | 68151-1028-8 | I | Inactivated by FDA | 2026-08-03 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A075360-001 | GABAPENTIN | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2005-04-06 | |
| A075360-002 | GABAPENTIN | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2005-04-06 | |
| A075360-003 | GABAPENTIN | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2005-04-06 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A075360-001 | AB |
| A075360-002 | AB |
| A075360-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A075360-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2005-04-06 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A075360-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2005-04-06 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A075360-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2005-04-06 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A075360-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A075360-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A075360-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GABAPENTIN | GABAPENTIN | Granules Pharmaceuticals Inc | c681c804-c6f3-d63b-e053-2995a90a6b8f | 2026-06-17 | Warnings, Adverse reactions | 075360 ANDA075360 |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | 397fd6d3-317b-4b61-a52b-3a09ca1d88a4 | 2026-05-22 | Warnings, Adverse reactions | 075360 ANDA075360 |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | 13640281-26b4-402e-8f69-7c81cd6e0376 | 2026-05-22 | Warnings, Adverse reactions | 075360 ANDA075360 |
| GABAPENTIN | GABAPENTIN | ST. MARY'S MEDICAL PARK PHARMACY | 3aaf3d6e-c6d5-89f5-e063-6394a90a9b77 | 2025-12-29 | Warnings, Adverse reactions | 075360 ANDA075360 |
| GABAPENTIN | GABAPENTIN | Granules Pharmaceuticals Inc. | b20ee34a-7f2d-4d62-a161-898565f74547 | 2025-12-02 | Warnings, Adverse reactions | 075360 ANDA075360 |
| Gabapentin | GABAPENTIN | Advanced Rx Pharmacy of Tennessee, LLC | c859e666-d510-426b-e053-2995a90a9a3c | 2024-12-31 | Warnings, Adverse reactions | 075360 ANDA075360 |
| GABAPENTIN | GABAPENTIN | Asclemed USA, Inc. | 5fb79774-c2d4-47ba-9a16-eb367d0fdcff | 2023-09-30 | Warnings, Adverse reactions | 075360 ANDA075360 |
| GABAPENTIN | GABAPENTIN | Proficient Rx LP | aa3ab216-372a-4a72-bfd1-88a1ffa31ba3 | 2022-05-01 | Warnings, Adverse reactions | 075360 ANDA075360 |
| GABAPENTIN | GABAPENTIN | Proficient Rx LP | 185f264e-db32-41cd-b90d-519717b97850 | 2021-11-01 | Warnings, Adverse reactions | 075360 ANDA075360 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| cdc2ae60-922e-452d-a42f-787fe4e2ed06 | Product name | 1 | 20250123 |
| 7059096a-4b9f-36c2-db50-bb5c723e6e9e | Product name | 2 | 20250114 |
| fa3f0129-3502-889f-f424-3a37727959e7 | Product name | 9 | 20181206 |
| 77d89e4c-f57f-326d-d7aa-787f8eebbd2b | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68151-1028-8 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-417d-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use GABAPENTIN safely and effectively. See full prescribing information for GABAPENTIN. GABAPENTIN capsules, USP for oral use GABAPENTIN tablets, USP for oral use Initial U.S. Approval: 1993 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68151-1028-8 | Gabapentin | 1 in 1 BOTTLE | CAPSULE | 1 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68151-1028 | GABAPENTIN CAPSULE [CARILION MATERIALS MANAGEMENT] | 2 | Legacy NDC, 1 package rows | 20160616_fd0d48d6-2cfb-4221-bedc-1b16121f4d05.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 310430 | gabapentin 100 MG Oral Capsule | PSN | fd0d48d6-2cfb-4221-bedc-1b16121f4d05 | 2 |
| 310430 | gabapentin 100 MG Oral Capsule | SCD | fd0d48d6-2cfb-4221-bedc-1b16121f4d05 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Status |
|---|---|---|---|
| 68151-1028-8 | 68151102808 | 1 in 1 BOTTLE | Historical |